» Articles » PMID: 37088861

Efficacy and Postoperative Outcomes of Laparoscopic Retrosternal Route Creation for the Gastric Conduit: Propensity Score-Matched Comparison to Posterior Mediastinal Reconstruction

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2023 Apr 23
PMID 37088861
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Retrosternal reconstruction has lower risks for severe postoperative morbidities, such as gastro-tracheal fistula or esophageal hiatal hernia. We have previously reported the laparoscopic retrosternal route creation (LRRC) method, but its safety and efficacy remain unclear.

Methods: In total, 374 patients with esophageal carcinoma who underwent minimally invasive McKeown esophagectomy in the prone position between 2010 and 2021 were retrospectively reviewed. We performed a propensity score-matched analysis with the simple, nearest-neighbor method and no calipers to compare postoperative outcomes and reconstructed gastric conduit functionality between patients who underwent LRRC and counterparts who underwent posterior mediastinal reconstruction.

Results: After matching, 62 patients were included in the laparoscopic retrosternal group (LR group) or posterior mediastinal group (PM group). No significant differences were observed between the groups, apart from the number of robot-assisted surgeries, the extent of lymph node dissection, and the method of cervical anastomosis. There were no significant differences in the incidence of Clavien-Dindo grade ≥ 2 complications. Gastro-tracheal fistula (n = 1) and esophageal hiatal hernia (n = 2) occurred in the PM group but not in the LR group. There were no differences in the incidence of pulmonary embolism between the groups (5% vs. 5%). The postoperative anastomotic stenosis rate was similar (16% vs. 27%, p = 0.192). Endoscopic findings of reflux esophagitis (modified Los Angeles classification ≥ M) at 1 year after surgery were significantly better in the LR group (p = 0.037).

Conclusions: LRRC for gastric conduit reconstruction is safe and valuable. It is associated with good reconstructed gastric conduit function.

Citing Articles

Prognostic impact of endoscopic response evaluation after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a nationwide validation study.

Matsuda S, Kitagawa Y, Okui J, Okamura A, Kawakubo H, Takemura R Esophagus. 2023; 20(3):455-464.

PMID: 36964333 DOI: 10.1007/s10388-023-00998-x.


ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?.

Morimoto Y, Matsuda S, Kawakubo H, Nakamura K, Kobayashi R, Hisaoka K Ann Surg Oncol. 2023; 30(6):3757-3758.

PMID: 36807023 DOI: 10.1245/s10434-023-13255-3.

References
1.
Biere S, van Berge Henegouwen M, Maas K, Bonavina L, Rosman C, Garcia J . Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012; 379(9829):1887-92. DOI: 10.1016/S0140-6736(12)60516-9. View

2.
Yasuda T, Sugimura K, Yamasaki M, Miyata H, Motoori M, Yano M . Ten cases of gastro-tracheobronchial fistula: a serious complication after esophagectomy and reconstruction using posterior mediastinal gastric tube. Dis Esophagus. 2012; 25(8):687-93. DOI: 10.1111/j.1442-2050.2011.01309.x. View

3.
Oor J, Wiezer M, Hazebroek E . Hiatal Hernia After Open versus Minimally Invasive Esophagectomy: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2016; 23(8):2690-8. DOI: 10.1245/s10434-016-5155-x. View

4.
Horikawa M, Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M . Laparoscopic creation of a retrosternal route for gastric conduit reconstruction. Surg Endosc. 2021; 36(4):2680-2687. DOI: 10.1007/s00464-021-08745-y. View

5.
Zheng Y, Dai S, Li W, Cao X, Wang X, Fu J . Comparison between different reconstruction routes in esophageal squamous cell carcinoma. World J Gastroenterol. 2012; 18(39):5616-21. PMC: 3482650. DOI: 10.3748/wjg.v18.i39.5616. View